FindTrial
Sign In

Assessment of Bone Mineral Density Using DEXA Scan for Early Diagnosis of Metabolic Bone Disease in Preterm Low Birth Weight Infants

Dual Energy X ray Absorptiometry Measured Bone Mineral Density as a Diagnostic Tool for Metabolic Bone Disease of Prematurity and Its Correlation with Biochemical Markers A One Year Prospective Observational Study in a Tertiary Care Centre - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110858
Enrollment
118
Registered
2026-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Preterm infants born at less than or equal to 32 weeks of gestation and or with a birth weight of less than or equal to 1500 g, whose parents or legal guardians are willing to provide informed consent, will be included in the study

Exclusion criteria

Exclusion criteria: Congenital bone disorders Skeletal dysplasia s like Achondroplasia, Osteogenesis Imperfecta, Congenital rickets, Hypophosphatemia and Mucopolysaccharidosis, Major congenital anomalies incompatible with study procedures, Infant clinically unstable for transfer to DEXA and Parental refusal are excluded from study

Design outcomes

Primary

MeasureTime frame
To determine the accuracy of DEXA- to diagnose BMD compared biochemical markers in preterm infantsTimepoint: 8 weeks—

Secondary

MeasureTime frame
Identify optimal DEXA Bone Mineral Density cut-offs for diagnosing MBD Compare DEXA values with biochemical markers ALP, serum phosphate.Timepoint: 8 weeks—

Countries

India

Contacts

Public ContactDr H Khizer Basha

JNMC ,Belagavi

drdhadedsm@gmail.com9844232586

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026